Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0HG4U
|
||||
Former ID |
DNC013626
|
||||
Drug Name |
(R)-(-)-2-Phenyl-apomorphine hydrochloride
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529328] | ||
Structure |
Download2D MOL |
||||
Formula |
C23H22ClNO2
|
||||
Canonical SMILES |
CN1CCC2=CC(=CC3=C2C1CC4=C3C(=C(C=C4)O)O)C5=CC=CC=C5.Cl
|
||||
InChI |
1S/C23H21NO2.ClH/c1-24-10-9-16-11-17(14-5-3-2-4-6-14)12-18-21(16)19(24)13-15-7-8-20(25)23(26)22(15)18;/h2-8,11-12,19,25-26H,9-10,13H2,1H3;1H/t19-;/m1./s1
|
||||
InChIKey |
MSZOZSZESCSJNX-FSRHSHDFSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | D(2) dopamine receptor | Target Info | Inhibitor | [529328] | |
D(3) dopamine receptor | Target Info | Inhibitor | [529328] | ||
WikiPathways | Hypothetical Network for Drug Addiction | ||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
Genes and (Common) Pathways Underlying Drug Addiction | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
Nicotine Activity on Dopaminergic NeuronsWP58:Monoamine GPCRs | |||||
Nicotine Activity on Dopaminergic Neurons | |||||
GPCRs, Other | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.